https://www.researchfrc.com/company/monument-mining-ltd/
RE:Analyst Coverage
https://www.researchfrc.com/monument-mining-limited-tsxv-mmy-fse-d7q1-gold-producer-trading-below-cash-initiating-coverage/
Working capital of US$33M, with no debt. MCAP of US$25M implies that the market is assigning zero value to its assets.
nozzpack (1869)
User Actions
July 15, 2022 - 09:22 PM
39 Reads
Post# 34828499
RE:RE:RE:RE:Analyst Coverage
It is important to remember that, as a main asset, cash and cash equivalents can be and usually are, signifucantly discounted by the market.
Monument's production rate has been cratering for 7-8 years, with little or no effort made to explore/ develop new sources of oxides at Selinsing or develop Murchisin due to almost all of its working capital
having been wasted on Mengaoher.
The turnaround began in late 2020 through dissenting pressure when Dato came onboard at which time right siding began with the sale of Mengapher, enhanced exploration of Murchison, pit development at Peranghi and monetization of the sulphide resources via the Floatation Plant.
So, we are now a much different company which has passed its nadir but not yet benefiting from the fruit of our capital investment in the FP.
And, in the summer doldrums of PM pricing among other issues.
In short, going from little to report other than pit scraping for the few remaining ounces of oxides, to soon having a strong production profile while retaining a strong debt free balance sheet.
We are not there yet and Cathy et al will be given very little time to demonstrate that they have the chops to move us to fair value.
Insiders residing on the current BOD own nearly 90 million shares.
They are as equally piffed off as us.
Things will change over the next few months
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169177432
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM